ODG
MED icon

O'Dell Group’s Medifast MED Stock Holding History

O'Dell Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4
Closed – – 273
2022
Q3 		$0 Buy
+4
New +$573 ﹤0.01% 467

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

O'Dell Group's MED Position: Q4 2022 in Review

O'Dell Group sold out of Medifast (MED) in Q4 2022, closing a stake of 4 shares.

O'Dell Group first reported a position in MED in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

  • O'Dell Group reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
  • O'Dell Group sold 4 Medifast shares in Q4 2022.
  • O'Dell Group first reported a position in Medifast in Q3 2022 and held it in 1 quarter.
  • O'Dell Group's Medifast position peaked at $0 in Q3 2022.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on O'Dell Group's 13F filing for Q4 2022, filed 14 Feb 2023.